# K-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C Mutation

> **NCT06127940** · PHASE1 · UNKNOWN · sponsor: **Karolinska University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer Metastatic

## Interventions

- **RADIATION:** Stereotactic body radiation therapy (SBRT)
- **DRUG:** Temporary Stopping

## Key facts

- **NCT ID:** NCT06127940
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-15
- **Primary completion:** 2025-06-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-11-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06127940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06127940, "K-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C Mutation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06127940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*